Physician profile
Abraham A Cherrick
NPI 1700854577
$8,590.85
in general payments reported to CMS, 2019-2025
58 companies · $591 in 2025
The $591 reported for 2025 was more than what 81% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $1,841 · 2021: $1,781 · 2022: $1,124 · 2023: $1,019 · 2024: $873 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,482.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,007.61 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $799.75 | 2021-2024 | Ubrelvy, Qulipta |
| Biodelivery Sciences International, INC. | $792.86 | 2020-2021 | |
| Vertos Medical, INC. | $546.13 | 2021-2024 | Mild Device Kit |
| Abbott Laboratories | $491.23 | 2019-2024 | Proclaim |
| Boston Scientific Corporation | $413.46 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $241.49 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $240.65 | 2019-2025 | |
| Pfizer INC. | $229.04 | 2019-2025 | |
| Lilly USA, LLC | $218.36 | 2019-2022 | |
| Allergan, INC. | $197.58 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $191.67 | 2022 | |
| Grt US Holding, INC. | $183.28 | 2021-2022 | |
| Relievant Medsystems, INC. | $180.85 | 2022-2023 | Intracept |
| Biohaven Pharmaceuticals, INC. | $177.94 | 2021 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Cherrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.